معرفی
Jane N Winter, MD is a Professor of Medicine in the Division of Hematology and Oncology at Northwestern University's Feinberg School of Medicine, specializing in lymphoma and leukemia. A nationally recognized expert, she served as President of the American Society of Hematology (2021-2022) and currently leads pivotal clinical trials in Hodgkin lymphoma.
Her educational background includes:
- MD from University of Pennsylvania (1977)
- Medicine Internship at University of Chicago (1978)
- Medicine Residency at University of Chicago Hospitals (1980)
- Hematology-Oncology Fellowship at Columbia Presbyterian Hospital (1981)
- Hematology-Oncology Fellowship at Northwestern University (1982)
Dr. Winter's research centers on hematologic malignancies with emphasis on Hodgkin's lymphoma, non-Hodgkin lymphoma, and immunotherapy development. Her work bridges clinical trial design, prognostic modeling, and real-world outcomes analysis to advance personalized lymphoma treatment.
Recent publications reveal a strong trajectory toward immunotherapy integration, particularly checkpoint inhibitors and CAR T-cell therapies, with focus on safety profiling, cardiotoxicity management, and biomarker-driven prognostication across diverse lymphoma subtypes.
Her accolades include annual recognition as Chicago's Top Doctor since 2003 and America's Top Doctor (2001-2007), alongside distinguished honors:
- Paula H. Stern Award for Outstanding Women in Medicine and Science (2020)
- Elliott Osserman Award (2002)
- Exceptional Women in Medicine (2024)
- Best Doctors in America (2007)
As principal investigator for multiple NCI-supported trials including COG AHOD2131 NU, Dr. Winter directs research evaluating brentuximab vedotin and nivolumab combinations for Hodgkin lymphoma. Her mentorship spans hematology/oncology trainees through the Lurie Cancer Center's clinical and research programs.
She co-leads the Robert H. Lurie Comprehensive Cancer Center's lymphoma program and serves on the NCCN Hodgkin Guidelines Committee, driving national treatment standards through the Simpson Querrey Institute for Epigenetics and Children's Oncology Group collaborations.
